Heterogeneity of Glucose Transport in Lung Cancer.

Biomolecules
Cesar A Martinez, Claudio Scafoglio

Abstract

Increased glucose uptake is a known hallmark of cancer. Cancer cells need glucose for energy production via glycolysis and the tricarboxylic acid cycle, and also to fuel the pentose phosphate pathway, the serine biosynthetic pathway, lipogenesis, and the hexosamine pathway. For this reason, glucose transport inhibition is an emerging new treatment for different malignancies, including lung cancer. However, studies both in animal models and in humans have shown high levels of heterogeneity in the utilization of glucose and other metabolites in cancer, unveiling a complexity that is difficult to target therapeutically. Here, we present an overview of different levels of heterogeneity in glucose uptake and utilization in lung cancer, with diagnostic and therapeutic implications.

References

Jul 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·R J Turner, M Silverman
Apr 11, 1977·Biochemical and Biophysical Research Communications·R K BanerjeeE Racker
May 1, 1992·The American Journal of Physiology·J H DominguezW T Garvey
Dec 1, 1990·The American Journal of Physiology·B ThorensH F Lodish
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·H FukumotoG I Bell
Sep 6, 1985·Science·M MuecklerH F Lodish
Apr 29, 1974·Biochimica Et Biophysica Acta·M Hatanaka
Sep 1, 1984·Journal of Reproduction and Fertility·H J Leese, A M Barton
May 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·K Suzuki, T Kono
Jul 8, 1980·Biochimica Et Biophysica Acta·I SussmanD F Wilson
Feb 1, 1994·European Journal of Biochemistry·M Mueckler
Apr 1, 1996·The Biochemical Journal·T Kasahara, M Kasahara
Jul 1, 1996·Physiological Reviews·H F Bunn, R O Poyton
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·M PantaleonP L Kaye
Oct 23, 1997·Nature Medicine·A E StenbitM J Charron
Jul 10, 1999·The Journal of Biological Chemistry·A BarthelR A Roth
May 24, 2000·The Journal of Biological Chemistry·R C OsthusC V Dang
Aug 19, 2000·American Journal of Physiology. Endocrinology and Metabolism·D Rivenzon-SegalH Degani
Dec 30, 2000·The Journal of Biological Chemistry·C ChenA Maity
Aug 18, 2001·Japanese Journal of Cancer Research : Gann·N IshikawaN Kohno
Oct 17, 2001·The Journal of Biological Chemistry·A Díez-SampedroB A Hirayama
Feb 8, 2002·American Journal of Physiology. Endocrinology and Metabolism·Suzanne RogersJames D Best
Jul 24, 2002·FEBS Letters·Marc UldryBernard Thorens
Oct 31, 2002·Nature Immunology·Gavin P DunnRobert D Schreiber
Aug 14, 2003·Biochemical and Biophysical Research Communications·Suzanne RogersJames D Best
Sep 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ana Diez-SampedroHermann Koepsell
Feb 24, 1956·Science·O WARBURG

❮ Previous
Next ❯

Citations

Dec 20, 2020·Cancers·Pasquale SaggeseClaudio Scafoglio
Jan 21, 2021·International Journal of Molecular Sciences·Russel J ReiterSergio Rosales-Corral
May 1, 2021·Metabolites·Ezequiel MonferrerTomás Álvaro Naranjo

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation
single-cell sequencing
chromosomal aberrations

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.